Rezum for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

The routine commissioning of Rezum is accepted in Devon for the treatment of patients with lower urinary tract symptoms caused by benign prostatic hyperplasia.

Policy published: 31 October 2022

Filename:	Rezum for lower urinary tract symptoms secondary to benign prostatic hyperplasia
Filetype:	pdf
Filesize:	119.52 KB
Date uploaded:	28th May 2019
Date updated:	31st October 2022

Clinical commissioning policies, Obstetrics, gynaecology and urinary tract disorder, Surgery Download